These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1468 related articles for article (PubMed ID: 1863023)

  • 1. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry.
    D'Alonzo GE; Barst RJ; Ayres SM; Bergofsky EH; Brundage BH; Detre KM; Fishman AP; Goldring RM; Groves BM; Kernis JT
    Ann Intern Med; 1991 Sep; 115(5):343-9. PubMed ID: 1863023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Value of Follow-Up Hemodynamic Variables After Initial Management in Pulmonary Arterial Hypertension.
    Weatherald J; Boucly A; Chemla D; Savale L; Peng M; Jevnikar M; Jaïs X; Taniguchi Y; O'Connell C; Parent F; Sattler C; Hervé P; Simonneau G; Montani D; Humbert M; Adir Y; Sitbon O
    Circulation; 2018 Feb; 137(7):693-704. PubMed ID: 29070502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival in primary pulmonary hypertension. Validation of a prognostic equation.
    Sandoval J; Bauerle O; Palomar A; Gómez A; Martínez-Guerra ML; Beltrán M; Guerrero ML
    Circulation; 1994 Apr; 89(4):1733-44. PubMed ID: 8149539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival.
    Sitbon O; Humbert M; Nunes H; Parent F; Garcia G; Hervé P; Rainisio M; Simonneau G
    J Am Coll Cardiol; 2002 Aug; 40(4):780-8. PubMed ID: 12204511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL).
    Benza RL; Miller DP; Gomberg-Maitland M; Frantz RP; Foreman AJ; Coffey CS; Frost A; Barst RJ; Badesch DB; Elliott CG; Liou TG; McGoon MD
    Circulation; 2010 Jul; 122(2):164-72. PubMed ID: 20585012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival in primary pulmonary hypertension with long-term continuous intravenous prostacyclin.
    Barst RJ; Rubin LJ; McGoon MD; Caldwell EJ; Long WA; Levy PS
    Ann Intern Med; 1994 Sep; 121(6):409-15. PubMed ID: 8053614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary pulmonary hypertension in children: clinical characterization and survival.
    Sandoval J; Bauerle O; Gomez A; Palomar A; Martínez Guerra ML; Furuya ME
    J Am Coll Cardiol; 1995 Feb; 25(2):466-74. PubMed ID: 7829802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary pulmonary hypertension. A national prospective study.
    Rich S; Dantzker DR; Ayres SM; Bergofsky EH; Brundage BH; Detre KM; Fishman AP; Goldring RM; Groves BM; Koerner SK
    Ann Intern Med; 1987 Aug; 107(2):216-23. PubMed ID: 3605900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Primary or of unknown etiology pulmonary hypertension: survival and its determinants].
    Sandoval Zárate J
    Gac Med Mex; 1994; 130(6):465-75. PubMed ID: 7557062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changing demographics, epidemiology, and survival of incident pulmonary arterial hypertension: results from the pulmonary hypertension registry of the United Kingdom and Ireland.
    Ling Y; Johnson MK; Kiely DG; Condliffe R; Elliot CA; Gibbs JS; Howard LS; Pepke-Zaba J; Sheares KK; Corris PA; Fisher AJ; Lordan JL; Gaine S; Coghlan JG; Wort SJ; Gatzoulis MA; Peacock AJ
    Am J Respir Crit Care Med; 2012 Oct; 186(8):790-6. PubMed ID: 22798320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five-Year outcomes of patients enrolled in the REVEAL Registry.
    Farber HW; Miller DP; Poms AD; Badesch DB; Frost AE; Muros-Le Rouzic E; Romero AJ; Benton WW; Elliott CG; McGoon MD; Benza RL
    Chest; 2015 Oct; 148(4):1043-54. PubMed ID: 26066077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Right Heart End-Systolic Remodeling Index Strongly Predicts Outcomes in Pulmonary Arterial Hypertension: Comparison With Validated Models.
    Amsallem M; Sweatt AJ; Aymami MC; Kuznetsova T; Selej M; Lu H; Mercier O; Fadel E; Schnittger I; McConnell MV; Rabinovitch M; Zamanian RT; Haddad F
    Circ Cardiovasc Imaging; 2017 Jun; 10(6):. PubMed ID: 28592589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Echocardiographic and Hemodynamic Predictors of Survival in Precapillary Pulmonary Hypertension: Seven-Year Follow-Up.
    Grapsa J; Pereira Nunes MC; Tan TC; Cabrita IZ; Coulter T; Smith BC; Dawson D; Gibbs JS; Nihoyannopoulos P
    Circ Cardiovasc Imaging; 2015 Jun; 8(6):. PubMed ID: 26063743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era.
    Humbert M; Sitbon O; Chaouat A; Bertocchi M; Habib G; Gressin V; Yaïci A; Weitzenblum E; Cordier JF; Chabot F; Dromer C; Pison C; Reynaud-Gaubert M; Haloun A; Laurent M; Hachulla E; Cottin V; Degano B; Jaïs X; Montani D; Souza R; Simonneau G
    Circulation; 2010 Jul; 122(2):156-63. PubMed ID: 20585011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary pulmonary hypertension in Israel: a national survey.
    Appelbaum L; Yigla M; Bendayan D; Reichart N; Fink G; Priel I; Schwartz Y; Richman P; Picard E; Goldman S; Kramer MR
    Chest; 2001 Jun; 119(6):1801-6. PubMed ID: 11399707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemodynamically Derived Pulmonary Artery Pulsatility Index Predicts Mortality in Pulmonary Arterial Hypertension.
    Mazimba S; Welch TS; Mwansa H; Breathett KK; Kennedy JLW; Mihalek AD; Harding WC; Mysore MM; Zhuo DX; Bilchick KC
    Heart Lung Circ; 2019 May; 28(5):752-760. PubMed ID: 29748060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of prognosis and associated risk factors in pediatric idiopathic pulmonary arterial hypertension].
    Liu Q; Zhang C; Li QQ; Zhu Y; Zhang D; Zhao WG; Gu H
    Zhonghua Er Ke Za Zhi; 2018 Jan; 56(1):23-28. PubMed ID: 29342993
    [No Abstract]   [Full Text] [Related]  

  • 18. Validation of the pulmonary hypertension connection equation for survival prediction in pulmonary arterial hypertension.
    Thenappan T; Glassner C; Gomberg-Maitland M
    Chest; 2012 Mar; 141(3):642-650. PubMed ID: 21885728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Risk factors for death and the clinical features of different subtypes of patients with pulmonary arterial hypertension related to congenital heart disease].
    Xu ZY; Li QQ; Zhang C; Zhang HS; Gu H
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):315-322. PubMed ID: 32370483
    [No Abstract]   [Full Text] [Related]  

  • 20. Portopulmonary hypertension: a report from the US-based REVEAL Registry.
    Krowka MJ; Miller DP; Barst RJ; Taichman D; Dweik RA; Badesch DB; McGoon MD
    Chest; 2012 Apr; 141(4):906-915. PubMed ID: 21778257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 74.